What is the BPC-157 + TB-500 Blend?

This research peptide formulation combines two well-characterised peptides—BPC-157 (5 mg) and TB-500 (Thymosin Beta-4 Acetate, 5 mg)—in a single 10 mg vial. Both peptides are supplied in lyophilised form at ≥98% purity as confirmed by HPLC analysis. This blend is formulated for laboratory-based research exploring cellular repair signalling, actin modulation pathways, and peptide interaction models.

Research Applications

• Study of multi-peptide cellular signalling pathways
• Research involving actin-binding proteins and peptide receptor activity
• In vitro tissue modelling and peptide synergy investigations
• Exploration of BPC and TB-500 peptide-based mechanisms

Key Features

• Contains BPC-157 (5 mg) and TB-500 (5 mg)
• Total peptide content: 10 mg per vial
• ≥98% purity (HPLC tested)
• Lyophilised for laboratory stability
• Batch-specific Certificate of Analysis (COA) available

Specifications

Reconstitution & Handling

• Reconstitute using bacteriostatic water or a suitable solvent
• Gently swirl until dissolved; do not shake vigorously
• Aliquot immediately after reconstitution if storing

Quality & Testing

Each batch is analysed using HPLC and mass spectrometry to confirm identity and purity. Batch documentation (COA) is available upon request for verification and research reproducibility.

Important Notice

For laboratory research use only. Not for human or veterinary use, medical diagnosis, treatment, or consumption.